The aim of this animal study is to assess fasting-induced changes in myocardial substrate metabolism and energy status as a consequence of mitochondrial long-chain fatty acid b-oxidation deficiency, using magnetic resonance spectroscopy (MRS).
Introduction
Under normal, well-fed conditions, the healthy heart relies on mitochondrial fatty acid b-oxidation (FAO) for a significant proportion (60-90%) of its energetic needs. Driven by the myocardial energy requirement and substrate availability, an adequate shift between fatty acid and glucose oxidation maintains sufficient myocardial ATP production during challenges such as exercise or fasting. 1 Patients with an inborn error in one of the enzymes of long-chain FAO are expected to have less metabolic flexibility, which may lead to myocardial energy shortage and consequently contribute to the development of hypertrophic cardiomyopathy observed in some patients. 2, 3 To gain more insight into the aetiology of cardiac disease in FAO disorders, mouse models are used to investigate the effects of FAO defects on cardiac function and morphology. The long-chain acyl-CoA dehydrogenase (LCAD) knockout (KO) mouse has been shown to display a phenotype similar to human very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency. 4, 5 LCAD KO mice have decreased cardiac performance after fasting, 6 whereas cardiac function is not affected by LCAD deficiency in fed conditions. 6, 7 This suggests that the LCAD KO mouse heart is able to compensate the FAO defect in the fed condition, but that this compensation fails upon fasting. Currently, the nature of these compensatory mechanisms and their consequences for the myocardial energy status are unknown. Using isolated working hearts perfused with radiolabeled substrates, the balance between glucose and fatty acid metabolism can be studied. 8 Substrate use, however, relies on circulating metabolite levels, which are different between wild-type (WT) and LCAD KO mice, 4, 9 and therefore difficult to mimic in perfusion experiments. The development of hyperpolarized carbon-13 magnetic resonance spectroscopy ( 13 C MRS) provides a non-invasive approach to assess myocardial substrate use in vivo by monitoring the production of bicarbonate (H 13 CO − 3 ) through the pyruvate dehydrogenase (PDH) complex upon infusion of hyperpolarized [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate. 10, 11 The contribution of glucose to ATP production is tightly regulated via dephosphorylation and phosphorylation of PDH, which respectively activates and inactivates the PDH complex. 12 PDH activity is decreased under conditions of elevated rates of FAO, e.g. during fasting. 13 In contrast to conventional tracer studies, hyperpolarized 13 C MRS measures the real-time in vivo 13 C label flux through the PDH complex. As such, it provides a direct measure of PDH complex activity, 14 which reflects the contribution of glucose metabolism to myocardial energy homeostasis.
In this animal study, we examined myocardial substrate metabolism in the LCAD KO mouse. We hypothesized that an altered metabolic response to fasting in LCAD KO mice would be reflected by differences in cardiac substrate use and energy status compared with WT mice. First, we measured myocardial deoxyglucose uptake in LCAD KO mice and WT mice in fed conditions and after a period of fasting. Next, in vivo myocardial PDH activity was assessed by means of hyperpolarized 13 C MRS in both the fed and the fasted state. The in vivo myocardial energy status was investigated using phosphorous-31 MRS ( 31 P MRS). Results were supplemented by in vivo magnetic resonance imaging (MRI) to quantify cardiac function, and biochemical assays on ex vivo tissue samples to measure PDH activity, gene expression, and metabolite concentrations. Our findings identify fasting-induced alterations in pyruvate metabolism, and an increased, but unmet need for anaplerosis in the LCAD KO mouse heart, accompanied by decreased myocardial energy status and impaired cardiac performance.
Methods

Animals
Male LCAD KO 4 and WT C57BL/6 mice were generated at the Animal Research Institute of the Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. All procedures conformed to the Directive 2010/63/EU of the European Parliament, and to institutional guidelines. MR data were acquired according to the protocols described below. Studies in the fed state were performed between 7 and 10 a.m., during the early absorptive state. On a separate day, mice were weighed, transferred to a clean cage without food, but with access to water, and fasted for 20 -24 h, followed by measurements in the fasted state. Finally, anaesthetized mice were sacrificed in the fasted state. The heart was rapidly excised, frozen in liquid nitrogen, and stored at 2808C for biochemical analyses.
Myocardial deoxyglucose uptake
To quantify the myocardial glucose uptake, we measured the conversion of radiolabeled deoxyglucose to phosphodeoxyglucose in hearts of fed and fasted animals. A separate cohort of mice received 76 kBq 2-[U- 14 C]deoxy-D-glucose (Perkin Elmer) in 0.9% NaCl (250 mL i.p.) in fed (n ¼ 6 per genotype) and fasted (n ¼ 6 per genotype) conditions. Blood glucose and radioactivity was measured at 0, 20 and 40 min after injection. Subsequently, mice were sacrificed by cervical dislocation, after which the heart was rapidly excised and frozen in liquid nitrogen. Tissue was homogenized in water using an Ultra-Turrax, after which the homogenate was heated to 958C in a water bath for 30 min. Next, samples were centrifuged for 10 min at maximal speed. The supernatant was applied on an anion exchange column (1X8-200, Dowex) in order to separate phosphodeoxyglucose from deoxyglucose. Myocardial deoxyglucose uptake was calculated by dividing the uptake of phosphodeoxyglucose in disintegrations per minute (dpm)/mg protein by the area under the curve of the blood deoxyglucose label per blood glucose molecule (dpm/nmol glucose). 15 C surface coil (Ø 20 mm) was positioned carefully over the chest, localizing signal from the heart. 16 The setup was entered into a horizontal-bore 7T MR scanner (Varian, Yarnton, UK). After confirming accurate placement of the surface coil with axial scout images, shimming was performed manually to reduce the water linewidth to 120 Hz. An ECG-triggered pulse-acquire 13 C MRS sequence was started, immediately followed by injection of 0.2 mL 80 mM hyperpolarized [1- 13 C]pyruvate solution. 16 In a separate set of experiments, the metabolic effect of pyruvate infusion in mice was investigated by measuring pyruvate, lactate, b-hydroxybutyrate, and glucose levels in blood samples collected at multiple time points after a 0.2-mL injection of 80 mM sodium pyruvate solution.
Assessment of in vivo
14 Full details are available in the Supplementary material online.
13 C MRS data analysis
Spectral fitting was performed using the AMARES algorithm in jMRUI. 17 The [1-13 C]pyruvate resonance at 170 ppm was used as an internal chemical shift reference, and other peaks were assigned according to reports in the literature. 11, 18 Signal amplitudes were input to a kinetic model, 14 yielding the rate
] of 13 C label incorporation from [1-13 C]pyruvate into its metabolic products. The rate constant of 13 C label flux through the PDH complex into the bicarbonate pool was used as a measure for in vivo myocardial PDH activity. For the assessment of 13 C label incorporation into malate and aspartate, spectra acquired over 40 s after [1-
13
C]pyruvate arrival were summed to increase the signal-to-noise ratio.
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In vitro PDH activity assay
Myocardial PDH activity was determined spectrophotometrically in tissue obtained from fasted mice as described previously. 14, 19 Activity is reported as micromoles NADH produced per minute per gram wet weight.
Cardiac 31 P MRS protocol
Localized 31 P MRS was performed to assess the in vivo myocardial energy status in fed and fasted conditions. Mice (n ¼ 7 per genotype) were transferred to the animal facilities at the Eindhoven University of Technology, The Netherlands. Mice were anaesthetized with 2% isoflurane in 0.4 L/min medical air and positioned prone in a purpose-built support cradle. The heart was carefully aligned over a custom-built, actively decoupled, two-turn 31 P surface coil (Ø 15 mm) for signal reception. ECG and respiration signals were monitored and used for MR triggering and gating. Mouse body temperature was maintained using a heating pad with integrated warm water flow. Anaesthesia was maintained with 1-1.5% isoflurane in 0.4 L/min medical air provided through and scavenged from a nose cone. The setup was entered into a horizontal-bore 9.4T magnet (Magnex Scientific, Oxon, UK) interfaced to a Bruker Avance III console (Bruker BioSpin MRI, Ettlingen, Germany) and equipped with a H imaging and shimming, and for radiofrequency transmission for 31 P MRS. Localized shimming was performed by minimizing the water line width using a cardiac-triggered, respiratory-gated point-resolved spectroscopy sequence. 6 Next, a cardiactriggered, respiratory-gated Image Selected In vivo Spectroscopy (ISIS) sequence was used for localized cardiac 31 P MRS. 20 A 125-216 mL cubic voxel was positioned to enclose the end-diastolic left ventricle (LV), excluding the liver and skeletal muscle. ISIS parameters were: TR ¼ 2 s; 96 ISIS cycles; 6.25 ms hyperbolic secant inversion pulse (bandwidth ¼ 37.5 ppm); 1.2 ms 908 sinc excitation pulse (bandwidth ¼ 32.0 ppm); g-ATP on-resonance. Triggering was timed at ECG R-wave upslope detection. Dummy excitations were performed during respiratory gates to maintain a constant TR. To correct for partial saturation, unlocalized spectra of the chest were acquired at TR ¼ 2 s and TR ¼ 15 s using a pulse-acquire sequence.
31 P MRS data analysis
PCr and ATP signal amplitudes were quantified using AMARES in jMRUI by fitting the peaks to Lorentzian line shapes. 17 The PCr resonance was referenced to 0.00 ppm. The g-ATP resonance at 22.48 ppm was fitted by a doublet with equal amplitudes and a J-coupling constant of 17 Hz. The contribution of ATP from the blood to the spectra was shown to be less than 4%, and was considered marginal. 20 Myocardial energy status was expressed as the PCr/g-ATP ratio, corrected for partial saturation.
Cinematographic MRI and image analysis
To quantify LV systolic and diastolic function, high temporal resolution cinematographic MR images were obtained in fed and fasted conditions as previously described. 21 In brief, anaesthetized mice (n ¼ 8 per genotype) were positioned in a vertical-bore 11.7T magnet (Magnex Scientific) interfaced to a Bruker Avance console (Bruker Biospin MRI) and equipped with a birdcage RF coil (Ø 40 mm; RAPID Biomedical). LV cavity volumes were derived from equatorial LV images using threshold adjustment in ImageJ (National Institutes of Health, USA), and plotted as a function of time to quantify LV functional parameters.
Quantitative real-time PCR analysis
Total RNA was isolated from mouse myocardium collected in the fasted state using Trizol (Invitrogen) extraction, after which cDNA was prepared using the Superscript II Reverse Transcriptase kit (Invitrogen). Quantitative real-time reverse transcription PCR was performed as previously described. 5 
Ex vivo tissue metabolite concentrations
Steady-state concentrations of citric acid cycle intermediates were determined in heart tissue collected from animals sacrificed in the fasted state. Heart tissue ( 100 mg wet weight) was homogenized in 1 mL 8% (w/v) sulfosalicylic acid and 100 mL of internal standard (0.2 mM 2-phenylbutyric acid) using an Ultra-Turrax and sonication. Suspension was centrifuged (10 min, 14 000 g), after which the pH of the supernatant was adjusted to 7 by adding 30% NaOH dropwise. The keto-groups were subsequently oximated by addition of 5 mL 5 M hydroxylamine hydrochloride, and incubation at 608C for 30 min. Next, the sample was reacidified by adding 100 mL 37% HCl, and saturated with salt by adding 0.2 g NaCl. The organic acids were extracted twice by adding 3 mL ethylacetate. Both extracts were pooled and dried. The residue was derivatized by addition of 100 mL N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide, and incubation at 808C for 60 min. Next, the sample (1 mL) was analysed by gas chromatography -mass spectrometry (GC-MS). Myocardial propionylcarnitine concentration was determined as previously described. 
Statistical analysis
All data are presented as mean + SD. Statistical significance of genotype and fasting effects on the in vivo MR data was assessed using 2 × 2 mixed design ANOVA 22 with one within-subjects factor (nutritional state: fed or fasted)
and one between-subjects factor (genotype: WT or LCAD KO). ANOVA results are reported in Table 1 . In case the interaction between genotype and fasting was significant, the differences were evaluated in more detail by separately analysing the effects of genotype and fasting using Bonferronicorrected two-sided unpaired and paired t-tests, respectively. Differences in myocardial deoxyglucose uptake were assessed using two-way ANOVA with Bonferroni correction. The significance of genotype-dependent differences in in vitro PDH activity, metabolite levels or gene expression was determined using two-sided unpaired t-tests. The level of significance was set at P , 0.05.
Results
Sustained glucose demand in LCAD KO hearts upon fasting
As a measure for myocardial glucose uptake, we quantified the uptake of radiolabeled deoxyglucose in fed and fasted WT and LCAD KO mice ( Figure 1 ). Myocardial deoxyglucose uptake was similar in WT and LCAD KO mice in the fed state, and markedly decreased in WT mice upon fasting. In sharp contrast, myocardial deoxyglucose uptake in fasted LCAD KO mice was similar to the fed condition, indicating a sustained demand for glucose in the fasted LCAD KO heart.
Sustained PDH activity in LCAD KO hearts upon fasting
To evaluate whether the sustained demand for glucose translated into higher glucose oxidation rates, we assessed in vivo myocardial pyruvate metabolism in fed and fasted LCAD KO mice and controls, by quantifying 13 C label incorporation from hyperpolarized [1-13 C]pyruvate into its metabolic products using hyperpolarized 13 C MRS. The in vivo myocardial PDH activity, derived from 13 C label incorporation into bicarbonate, was similar for both genotypes in the fed state (Figure 2A) . PDH activity decreased in fasted animals, but was 2.7-fold higher in fasted LCAD KO mice compared with fasted WT mice (P , 0.05, Figure 2A) . The in vitro measurements of PDH activity in the fasted state mirrored the in vivo 13 C label flux through the PDH complex (P , 0.01, Figure 2B ). Labelling of lactate and alanine was unaffected by genotype or fasting ( Figure 2C  and D) . In fasted LCAD KO mice, summation of the spectra revealed peaks at chemical shifts corresponding to malate and aspartate ( Figure 2F) . Interestingly, these peaks could not be detected in any of the fed animals or in fasted WT mice ( Figure 2E ). The production of labelled malate and aspartate from [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate points to anaplerotic reactions in fasted LCAD KO myocardium. These data reveal a sustained myocardial PDH activity as well as changes in anaplerotic flux in the fasted LCAD KO mouse.
Low myocardial energy status in fasted LCAD KO mice
To assess the myocardial energy status, localized 31 P MRS was applied in vivo in LCAD KO mice and WT mice in fed and fasted conditions ( Figure 3A and B) . The myocardial PCr/g-ATP ratio was equal for WT mice and LCAD KO mice in the fed state. After fasting, the PCr/g-ATP ratio was 32% lower in fasted LCAD KO mice compared with fasted WT mice (P , 0.05, Figure 3C ).
Cardiac dysfunction upon fasting in LCAD KO mice
In order to determine the consequences of the observed metabolic changes on cardiac function in the LCAD KO mouse, we quantified cardiac performance using cine MRI ( Table 1) . LV end-diastolic volume (EDV) was similar in both genotypes and was not affected by fasting. Endsystolic volume was not affected by fasting, and was higher in LCAD KO mice (P , 0.05). In the fed state, stroke volume (SV) was similar for both genotypes. After fasting, SV was lower in LCAD KO mice than in WT mice (P , 0.05). Likewise, in LCAD KO mice, ejection fraction was normal in the fed state, but decreased after fasting (P , 0.05). Heart rate was lower in fasted animals (P , 0.001). Combined with the decreased SV in fasted LCAD KO mice, the cardiac output decreased by 41% in fasted LCAD KO mice compared with the fed condition (P , 0.01). Diastolic function was assessed by comparing the peak filling rates. Peak early filling rate (E ′ ) was similar in both genotypes and was not affected by fasting. In contrast, peak late filling rate (A ′ ) was lower in LCAD KO mice than in WT mice (P , 0.05), and was reduced by fasting in both genotypes (P , 0.01). Together, these data identify fasting-induced effects on cardiac function, which are mild in WT mice but result in substantially impaired LV performance in LCAD KO mice.
Low myocardial levels of citric acid cycle intermediates in fasted LCAD KO mice
To explore the mechanism behind the production of labelled malate and aspartate from [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate in fasted LCAD KO hearts, expression of genes involved in anaplerosis, and the concentrations of citric acid cycle intermediates were measured. Myocardial gene expression of cytosolic malic enzyme 1 (ME1), cytosolic malate dehydrogenase 1 (MDH1), mitochondrial malate dehydrogenase 2 (MDH2), and pyruvate carboxylase (PC) were similar in fasted WT and fasted LCAD KO mice (Figure 4) , as were the expressions of the mitochondrial isoforms of malic enzyme (ME2 and ME3; data not shown ( Figure 5 ). Lactate levels were 57% lower in fasted LCAD KO myocardium than in WT tissue (P , 0.001), whereas pyruvate levels were similar for both genotypes. Oxaloacetate, citrate, and a-ketoglutarate concentrations were similar for both genotypes, whereas both fumarate (258%, P , 0.0001) and L-malate (254%, P , 0.0001) levels were lower in fasted LCAD KO myocardium than in fasted WT myocardium. In addition, the myocardial concentration of propionylcarnitine (C3-carnitine) was lower in fasted LCAD KO mice than in fasted WT mice (P , 0.001). Propionylcarnitine is derived from propionyl-CoA, a metabolite in the degradation of branched-chain amino acids that can replenish the citric acid cycle with carbon skeletons. These data show that the myocardial pool of citric acid cycle intermediates is partially depleted in fasted LCAD KO mice, which is indicative of an increased, but unmet need for anaplerosis in LCAD KO hearts upon fasting.
Discussion
Adequate metabolic flexibility is essential for the heart to cope with nutritional challenges such as fasting. Metabolic flexibility is expected to be compromised in patients with long-chain FAO disorders. Until now, limited data were available on the contribution of glucose metabolism to myocardial energy homeostasis in the FAO-deficient heart. We investigated myocardial substrate metabolism in fed and fasted WT and LCAD KO mice using non-invasive MR measurements supplemented with ex vivo analyses. The LCAD KO mouse displays a phenotype similar to patients with long-chain FAO deficiencies, fasting-induced hypoglycaemia, and the development of hypertrophic cardiomyopathy. 4, 6, 7 Here, we show that myocardial glucose oxidation was normal in fed LCAD KO mice, as reflected by a deoxyglucose uptake C label incorporation into lactate (C) and alanine (D). Note: the presence of malate and aspartate resonance peaks in a summed spectrum acquired in a fasted LCAD KO mouse (F), which are absent in the spectrum from a fasted WT mouse (E). (A) *P , 0.05 vs. WT; §P , 0.01 vs. fed (2 × 2 mixed design ANOVA with Bonferroni correction); (B) *P , 0.01 vs. WT (two-sided unpaired t-test).
In vivo myocardial metabolism in LCAD KO mice and myocardial PDH activity similar to WT animals. In addition, myocardial energy status was not affected by LCAD deficiency, as evidenced by an equal PCr/g-ATP ratio in fed WT and LCAD KO mice. Upon fasting, myocardial deoxyglucose uptake did not decrease in LCAD KO mice, and myocardial PDH activity was higher in LCAD KO mice compared with WT mice, which was accompanied by a lower myocardial energy status as well as decreased cardiac performance.
Previously, 13 C MRS of hyperpolarized [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate was shown to allow for accurate assessment of in vivo myocardial PDH enzyme activity in rats 14 and mice, 16 capturing the fasting-induced switch in substrate utilization to FAO as glucose and pyruvate oxidation diminish. 11 Hyperpolarized
13
C MRS exploits its increased sensitivity to rapidly acquire data within one min after infusion of a bolus of hyperpolarized [1- C MRS data acquisition, the metabolic system and the PDH activity are not disturbed by the elevated pyruvate concentration. 14, 24, 25 This is supported by the unaltered blood levels of lactate, b-hydroxybutyrate, and glucose for up to 1 min after pyruvate injection (Supplementary material online). We show that the myocardial PDH activity in fed WT and LCAD KO mice is similar, indicating that in the fed state, glucose oxidation is not increased to compensate for LCAD deficiency. Indeed, myocardial uptake of deoxyglucose was similar for both genotypes in fed conditions. In the fasted state, the WT mouse heart is almost exclusively reliant on FAO, 13 as evidenced by the marginal myocardial PDH activity observed in fasted WT mice in combination with the low uptake of deoxyglucose in fasted WT hearts. In contrast, the PDH activity in LCAD KO mice remained higher after fasting than in WT mice. The in vivo 13 C label flux from [1-
C]pyruvate through the PDH complex into bicarbonate was in very close agreement with the PDH activity measured spectrophotometrically, further validating this approach for use in genetically modified mouse models. 16 The higher PDH activity observed in fasted LCAD KO myocardium may be explained by lower levels of mitochondrial acetyl-CoA in the FAO-deficient heart, which relieve the regulatory end-product Figure 4 Relative myocardial gene expression levels for anaplerotic enzymes in fasted WT (n ¼ 7) and LCAD KO (n ¼ 7) mice. ME1, cytosolic malic enzyme 1; PC, pyruvate carboxylase; MDH1, malate dehydrogenase 1; MDH2, malate dehydrogenase 2. Figure 5 Myocardial steady-state concentrations of lactate, pyruvate, citric acid cycle intermediates, and propionylcarnitine in fasted WT (n ¼ 7) and LCAD KO (n ¼ 10) mice. *, P , 0.001 (two-sided unpaired t-test).
In vivo myocardial metabolism in LCAD KO mice inhibition of the PDH complex. 13, 26 Furthermore, myocardial deoxyglucose uptake was sustained in fasted LCAD KO mice despite prevailing hypoglycaemia. 4 Together, these findings reflect the glucose-sparing effect of FAO during fasting, 1 which is compromised in the LCAD KO mouse, resulting in an elevated reliance on glucose oxidation of the LCAD KO mouse heart during fasting. Given the reduced PCr/g-ATP ratio in fasted LCAD KO mice, the maintained glucose uptake in the fasted LCAD KO myocardium might be mediated by AMP-activated protein kinase (AMPK). 27 However, we have not been able to demonstrate enhanced AMPK activation in these mice. Alternatively, the efficient glucose uptake by the fasted LCAD KO myocardium may be mediated by a steeper glucose concentration gradient across the sarcolemma, subsequent to the enhanced glucose metabolism in fasted LCAD KO cardiomyocytes. The fact that LCAD KO mice are hypoglycemic during fasting illustrates their metabolic rigidity. C]pyruvate injection demonstrates enhanced activity of these anaplerotic pathways in the fasted LCAD KO heart compared with the WT heart. Since this difference could not be explained by increased expression of anaplerotic enzymes, the increased in vivo flux through these enzymes must be due to decreased product inhibition or increased allosteric activation in the fasted LCAD KO mouse. The lower steady-state concentration of L-malate in fasted LCAD KO myocardium suggests that decreased product inhibition of malic enzyme is the most likely contributor to the observed increased anaplerotic flux in the fasted LCAD KO mouse heart. Together, these findings suggest an increased need for anaplerotic compounds in the fasted LCAD KO myocardium, which cannot be met due to low substrate availability.
In patients with VLCAD deficiency, the administration of dietary anaplerotic odd-chain triglycerides led to an improvement of cardiomyopathy. 29 This has been attributed to increased availability of precursors of propionyl-CoA, which is an important anaplerotic substrate at the level of succinyl-CoA. The therapeutic potential of dietary supplementation of odd-chain fatty acids is supported by our observations that citric acid cycle intermediates downstream of succinyl-CoA were depleted, and both plasma 9 and myocardial levels of propionylcarnitine were low in fasted LCAD KO mice. During fasting, amino acid metabolism provides anaplerotic precursors. 28 Depletion of citric acid cycle intermediates may therefore be indicative of impaired protein mobilization, which was shown to contribute to fasting-induced hypoglycaemia in LCAD KO mice. 30 Insufficient availability of oxidizable substrates may lead to myocardial energy shortage, and could contribute to the development of hypertrophic cardiomyopathy in patients with FAO disorders. 2 The principal method for assessment of the myocardial energy status is 31 P MRS. Here, we applied this technique to the in vivo mouse heart, showing that the myocardial energy status, in terms of PCr/g-ATP ratio, was similar in WT mice and LCAD KO mice in the fed state. The value obtained here (1.0 + 0.2) with cardiac-triggered, respiratory-gated 3D ISIS in fed WT mice is lower than those measured previously using 1D chemical shift imaging of healthy mice (2.0 + 0.2), 31 and lower than values generally reported for healthy hearts of animals as well as humans (1.7 + 0.3). 32 Most likely, these differences are attributable to differences in the methods used. 32 Although our method may underestimate the actual PCr/ATP ratio present in the mice included in this study, we were nonetheless able to demonstrate that the myocardial PCr/ g-ATP ratio was lower in fasted LCAD KO mice than in fasted WT mice. Importantly, this was accompanied by a fasting-induced decrease of cardiac performance in LCAD KO mice. Therefore, energy shortage may play a pivotal role in patients, where the cardiac phenotype can be more severe. Additionally, accumulation of lipotoxic mediators such as ceramide 33 may contribute to the development of cardiomyopathy associated with long-chain FAO disorders. 6 In conclusion, the present study reveals an elevated reliance of the heart on glucose oxidation in fasted LCAD KO mice, in combination with an increased, but unmet demand for myocardial anaplerosis. Due to hypoglycaemia, the sustained myocardial glucose uptake and PDH activity in LCAD KO mice are ineffective to maintain metabolic homeostasis during fasting, rendering the myocardial metabolic flexibility inadequate. This is reflected by a low myocardial energy status, an unmet need for anaplerosis, and impaired cardiac performance in fasted LCAD KO mice. These results warrant further investigations of therapeutic interventions that aim to reverse or prevent the cardiac phenotype in long-chain FAO disorders via anaplerotic pathways.
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